TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sotera Health ( (SHC) ) has shared an update.
On November 6, 2025, Sotera Health Company and certain stockholders entered into an underwriting agreement with Goldman Sachs & Co. LLC for the sale of 30,000,000 shares of common stock. The shares were sold on November 10, 2025, by the stockholders, and Sotera Health did not receive any proceeds from this transaction.
The most recent analyst rating on (SHC) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Sotera Health stock, see the SHC Stock Forecast page.
Spark’s Take on SHC Stock
According to Spark, TipRanks’ AI Analyst, SHC is a Neutral.
Sotera Health’s strong earnings performance and positive technical indicators are the primary drivers of its stock score. However, high debt levels and a high P/E ratio pose risks. The company’s strategic debt reduction and revenue growth provide a positive outlook, but profitability and litigation challenges remain concerns.
To see Spark’s full report on SHC stock, click here.
More about Sotera Health
Sotera Health Company operates in the health sector, focusing on providing sterilization and lab testing services to ensure the safety of healthcare products.
Average Trading Volume: 1,990,770
Technical Sentiment Signal: Buy
Current Market Cap: $4.45B
See more insights into SHC stock on TipRanks’ Stock Analysis page.